2017
DOI: 10.1186/s40169-017-0177-y
|View full text |Cite
|
Sign up to set email alerts
|

Using single‐cell multiple omics approaches to resolve tumor heterogeneity

Abstract: It has become increasingly clear that both normal and cancer tissues are composed of heterogeneous populations. Genetic variation can be attributed to the downstream effects of inherited mutations, environmental factors, or inaccurately resolved errors in transcription and replication. When lesions occur in regions that confer a proliferative advantage, it can support clonal expansion, subclonal variation, and neoplastic progression. In this manner, the complex heterogeneous microenvironment of a tumour promot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
48
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
4

Relationship

1
9

Authors

Journals

citations
Cited by 78 publications
(48 citation statements)
references
References 128 publications
(113 reference statements)
0
48
0
Order By: Relevance
“…Moreover, HMMcopy was designed for aCGH data originally, and thus does not take into account the specific error profiles that characterize single-cell sequencing data, such as low and uneven coverage, or the computational challenges that arise due to biological processes such as aneuploidy in a tumor single cell. While these three methods have been widely applied to analyze single-cell data [27,[31][32][33][34][37][38][39][40][41][42][43][44][45][46][47][48], a comprehensive study of their performance is currently lacking. While Knouse et al [32] assessed the performance of CBS and HMM-based methods on single-cell DNA sequencing data, their evaluation is limited to CNVs in brain and skin cells.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, HMMcopy was designed for aCGH data originally, and thus does not take into account the specific error profiles that characterize single-cell sequencing data, such as low and uneven coverage, or the computational challenges that arise due to biological processes such as aneuploidy in a tumor single cell. While these three methods have been widely applied to analyze single-cell data [27,[31][32][33][34][37][38][39][40][41][42][43][44][45][46][47][48], a comprehensive study of their performance is currently lacking. While Knouse et al [32] assessed the performance of CBS and HMM-based methods on single-cell DNA sequencing data, their evaluation is limited to CNVs in brain and skin cells.…”
Section: Introductionmentioning
confidence: 99%
“…Rather than being considered the "by-products" of scRNA-seq, the SNVs not only have the potential to improve the accuracy of identifying subpopulations compared to GE, but also offer unique opportunities to study the genetic events (genotype) associated with gene expression (phenotype) 17,18 . Moreover, when the coupled DNA-and RNA-based single-cell sequencing techniques become mature, the computational methodology proposed in this report can be adopted as well 19 .…”
Section: Introductionmentioning
confidence: 99%
“…Single‐cell sequencing, which allows profiling of single cells as opposed to bulk tumor tissue, has also been utilized to define the heterogeneity of gliomas (Khoo et al, ; Levitin, Yuan, & Sims, ; Ortega et al, ). This approach has enabled the dissection of heterogeneous cellular populations within tumors by identifying potential malignantly transformed cells (e.g., stem‐like subpopulations and sublineages of developmentally related cells) and cell types comprising tumor microenvironments (e.g., infiltrating immune populations and other stromal populations) in different types of brain tumors (Filbin et al, ; Patel et al, ; Tirosh & Suva, ).…”
Section: Glioma Heterogeneitymentioning
confidence: 99%